Mayo Clinic Proceedings Home

The Association of Active Cancer With Venous Thromboembolism Location: A Population-Based Study


      To test active cancer for an association with venous thromboembolism (VTE) location.


      Using the resources of the Rochester Epidemiology Project, we identified all Olmsted County, MN, residents with incident VTE during the 35-year period 1966-2000 (N=3385). We restricted analyses to residents with objectively diagnosed VTE during the 17-year period from January 1, 1984, to December 31, 2000 (N=1599). For each patient, we reviewed the complete medical records in the community for patient age, gender, and most recent body mass index at VTE onset; VTE event type and location; and previously identified independent VTE risk factors (ie, surgery, hospitalization for acute medical illness, active cancer, leg paresis, superficial venous thrombosis, and varicose veins). Using logistic regression we tested active cancer for an association with each of 4 symptomatic VTE locations (arm or intra-abdominal deep venous thrombosis [DVT], intra-abdominal DVT, pulmonary embolism, and bilateral leg DVT), adjusted for age, gender, body mass index, and other VTE risk factors.


      In multivariate analyses, active cancer was independently associated with arm or intra-abdominal DVT (odds ratio [OR], 1.76; P=.01), intra-abdominal DVT (OR, 2.22; P=.004), and bilateral leg DVT (OR, 2.09; P=.02), but not pulmonary embolism (OR, 0.93).


      Active cancer is associated with VTE location. Location of VTE may be useful in decision making regarding cancer screening.
      BMI (body mass index), CI (confidence interval), CTEPH (chronic thromboembolic pulmonary hypertension), DVT (deep venous thrombosis), OR (odds ratio), PE (pulmonary embolism), VTE (venous thromboembolism)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Prandoni P
        • Piccioli A
        • Girolami A
        Cancer and venous thromboembolism: an overview.
        Haematologica. 1999; 84: 437-445
        • Nordstrom M
        • Lindblad B
        • Anderson H
        • Bergqvist D
        • Kjellstrom T
        Deep venous thrombosis and occult malignancy: an epidemiological study.
        BMJ. 1994; 308: 891-894
        • Prandoni P
        • Lensing AW
        • Buller HR
        • et al.
        Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.
        N Engl J Med. 1992; 327: 1128-1133
        • Cormack J
        Phlegmasia alba dolens.
        in: Trousseau A Lectures on Clinical Medicine, Delivered at the Hotel-dieu, Paris. Lindsay & Blackiston, Philadelphia, PA1872: 281-295
        • Heit JA
        • Silverstein MD
        • Mohr DN
        • Petterson TM
        • O'Fallon WM
        • Melton III, LJ
        Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.
        Arch Intern Med. 2000; 160: 809-815
        • Heit JA
        Risk factors for venous thromboembolism.
        Clin Chest Med. 2003; 24: 1-12
        • Khorana AA
        • Francis CW
        • Culakova E
        • Kuderer NM
        • Lyman GH
        Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.
        J Thromb Haemost. 2007; 5: 632-634
        • Sorensen HT
        • Mellemkjaer L
        • Olsen JH
        • Baron JA
        Prognosis of cancers associated with venous thromboembolism.
        N Engl J Med. 2000; 343: 1846-1850
        • Chew HK
        • Wun T
        • Harvey D
        • Zhou H
        • White RH
        Incidence of venous thromboembolism and its effect on survival among patients with common cancers.
        Arch Intern Med. 2006; 166: 458-464
        • Piccioli A
        • Lensing AW
        • Prins MH
        • et al.
        Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial.
        J Thromb Haemost. 2004; 2: 884-889
        • Lee AY
        Screening for occult cancer in patients with idiopathic venous thromboembolism: no.
        J Thromb Haemost. 2003; 1: 2273-2274
        • Lee AY
        • Levine MN
        • Baker RI
        • et al.
        Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
        N Engl J Med. 2003; 349: 146-153
        • Griffin MR
        • Stanson AW
        • Brown ML
        • et al.
        Deep venous thrombosis and pulmonary embolism: risk of subsequent malignant neoplasms.
        Arch Intern Med. 1987; 147: 1907-1911
        • Sorensen HT
        • Mellemkjaer L
        • Steffensen FH
        • Olsen JH
        • Nielsen GL
        The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism.
        N Engl J Med. 1998; 338: 1169-1173
        • Bura A
        • Cailleux N
        • Bienvenu B
        • et al.
        Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients.
        J Thromb Haemost. 2004; 2: 441-444
        • Melton III, LJ
        History of the Rochester Epidemiology Project.
        Mayo Clin Proc. 1996; 71: 266-274
        • Silverstein MD
        • Heit JA
        • Mohr DN
        • Petterson TM
        • O'Fallon WM
        • Melton III, LJ
        Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.
        Arch Intern Med. 1998; 158: 585-593
        • Heit JA
        Venous thromboembolism: disease burden, outcomes and risk factors.
        J Thromb Haemost. 2005; 3: 1611-1617
        • Kurland LT
        • Molgaard CA
        The patient record in epidemiology.
        Sci Am. 1981; 245: 54-63
        • Heit JA
        • Leibson CL
        • Ashrani AA
        • Petterson TM
        • Bailey KR
        • Melton III, LJ
        Is diabetes mellitus an independent risk factor for venous thromboembolism? a population-based case-control study.
        Arterioscler Thromb Vasc Biol. 2009; 29: 1399-1405
        • Wysokinski WE
        • Gosk-Bierska I
        • Greene EL
        • Grill D
        • Wiste H
        • McBane II, RD
        Clinical characteristics and long-term follow-up of patients with renal vein thrombosis.
        Am J Kidney Dis. 2008; 51: 224-232
        • McBane RD
        • Wysokinski WE
        Treatment of venous thrombosis at unusual sites.
        Curr Treat Options Cardiovasc Med. 2008; 10: 136-145
        • Sajid MS
        • Ahmed N
        • Desai M
        • Baker D
        • Hamilton G
        Upper limb deep vein thrombosis: a literature review to streamline the protocol for management.
        Acta Haematol. 2007; 118: 10-18
        • Joffe HV
        • Kucher N
        • Tapson VF
        • Goldhaber SZ
        Upper-extremity deep vein thrombosis: a prospective registry of 592 patients.
        Circulation. 2004; 110: 1605-1611
        • Blom JW
        • Doggen CJ
        • Osanto S
        • Rosendaal FR
        Old and new risk factors for upper extremity deep venous thrombosis.
        J Thromb Haemost. 2005; 3: 2471-2478
        • Martinelli I
        • Franchini M
        • Mannucci PM
        How I treat rare venous thromboses.
        Blood. 2008; 112: 4818-4823
        • Thatipelli MR
        • McBane RD
        • Hodge DO
        • Wysokinski WE
        Survival and recurrence in patients with splanchnic vein thromboses.
        Clin Gastroenterol Hepatol. 2010; 8: 200-205
        • Monreal M
        • Lensing AW
        • Prins MH
        • et al.
        Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism.
        J Thromb Haemost. 2004; 2: 876-881
        • Carrier M
        • Le Gal G
        • Wells PS
        • Fergusson D
        • Ramsay T
        • Rodger MA
        Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?.
        Ann Intern Med. 2008; 149: 323-333
        • Prandoni P
        • Lensing AW
        • Piccioli A
        • et al.
        Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.
        Blood. 2002; 100: 3484-3488
        • Geerts WH
        • Bergqvist D
        • Pineo GF
        • et al.
        Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition).
        Chest. 2008; 133(6): 381S-453S
        • Lyman GH
        • Khorana AA
        • Falanga A
        • et al.
        American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
        J Clin Oncol. 2007; 25: 5490-5505